Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

bayer ag, leverkusen array - 17443 klathrÁt ethinylestradiol-betadexu; 11275 drospirenon - potahovaná tableta - 0,02mg/3mg - drospirenon a ethinylestradiol

Israel - engelsk - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol - film coated tablets - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and estrogen - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone,ethinylestradiol -

Israel - engelsk - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol - film coated tablets - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bayer hispania s.l. - drospirenona; etinilestradiol - comprimido recubierto con pelÍcula - 3 mg/0,02 mg - drospirenona 3 mg; etinilestradiol 0,02 mg - drospirenona y estrógeno

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone; ethinyloestradiol -

USA - engelsk - NLM (National Library of Medicine)

cardinal health - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - pericyazine - oral suspension - 500microgram/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - pericyazine - oral solution - 500microgram/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - pericyazine - oral solution - 2mg/1ml